Karl-Erik Andersson1. 1. Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. karl-erik.andersson@klinfarm.lu.se
Abstract
AIMS: To discuss (1) mechanisms involved in the generation and control of myocyte contractions and consequent afferent nerve activity and (2) these mechanisms as targets for drugs aimed for treatment of overactive bladder (OAB) symptoms and detrusor overactivity (DO). METHODS: Literature review of myocyte activation, bladder afferent nerves, mediators in the bladder, and translational aspects of the findings. RESULTS: During bladder filling, there is normally no parasympathetic outflow from the spinal cord. Despite this, the bladder develops tone during filling and also exhibits non-synchronized local contractions and relaxations that are caused by a basal myogenic mechanical activity that may be reinforced by release of, for example, acetylcholine from non-neuronal and/or neuronal sources or local mediators, such as prostaglandins and endothelins. It is suggested that these spontaneous contractions are able to generate activity in afferent nerves ("afferent noise") that may contribute to DO and OAB. CONCLUSIONS: Spontaneous bladder myocyte contractions and factors that are able to modulate them, as well as the consequent afferent nerve activity, may be targets for drugs meant for treatment of OAB/DO.
AIMS: To discuss (1) mechanisms involved in the generation and control of myocyte contractions and consequent afferent nerve activity and (2) these mechanisms as targets for drugs aimed for treatment of overactive bladder (OAB) symptoms and detrusor overactivity (DO). METHODS: Literature review of myocyte activation, bladder afferent nerves, mediators in the bladder, and translational aspects of the findings. RESULTS: During bladder filling, there is normally no parasympathetic outflow from the spinal cord. Despite this, the bladder develops tone during filling and also exhibits non-synchronized local contractions and relaxations that are caused by a basal myogenic mechanical activity that may be reinforced by release of, for example, acetylcholine from non-neuronal and/or neuronal sources or local mediators, such as prostaglandins and endothelins. It is suggested that these spontaneous contractions are able to generate activity in afferent nerves ("afferent noise") that may contribute to DO and OAB. CONCLUSIONS: Spontaneous bladder myocyte contractions and factors that are able to modulate them, as well as the consequent afferent nerve activity, may be targets for drugs meant for treatment of OAB/DO.
Authors: Zachary E Cullingsworth; Adam P Klausner; Rui Li; Anna S Nagle; Ashley W Carroll; John T Roseman; John E Speich Journal: Neurourol Urodyn Date: 2019-12-19 Impact factor: 2.696
Authors: Bernhard Nausch; Frederik Rode; Susanne Jørgensen; Antonio Nardi; Mads P G Korsgaard; Charlotte Hougaard; Adrian D Bonev; William D Brown; Tino Dyhring; Dorte Strøbæk; Søren-Peter Olesen; Palle Christophersen; Morten Grunnet; Mark T Nelson; Lars C B Rønn Journal: J Pharmacol Exp Ther Date: 2014-06-20 Impact factor: 4.030
Authors: Pradeep Tyagi; Phillip P Smith; George A Kuchel; William C de Groat; Lori A Birder; Christopher J Chermansky; Rosalyn M Adam; Vincent Tse; Michael B Chancellor; Naoki Yoshimura Journal: Int Urol Nephrol Date: 2014-09-20 Impact factor: 2.370
Authors: Derek Sheen; Hiren Kolli; Anna S Nagle; Zachary Cullingsworth; Naomi N Vinod; Hameeda A Naimi; Stefan G De Wachter; Suzanne E Mazzeo; Lynn Stothers; John E Speich; Adam P Klausner Journal: Low Urin Tract Symptoms Date: 2019-07-12 Impact factor: 1.592
Authors: Qi Lei; Xiao-Qing Pan; Shaohua Chang; S Bruce Malkowicz; Thomas J Guzzo; Anna P Malykhina Journal: J Physiol Date: 2014-05-06 Impact factor: 5.182